Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
86.72
-0.64 (-0.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gilead Sciences
< Previous
1
2
3
4
5
6
7
8
9
...
50
51
Next >
Gilead's Trodelvy Fails To Hit Primary Goal In Late-Stage Study With Most Common Type Of Bladder Cancer
May 31, 2024
Gilead Sciences' announced topline results from the Phase 3 TROPiCS-04 study on Trodelvy for metastatic urothelial cancer. The study did not meet the primary endpoint of overall survival but showed...
Via
Benzinga
EVOKE-01 Study Results in Metastatic NSCLC to Be Presented at an Oral Session at ASCO 2024
May 31, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Provides Update on Phase 3 TROPiCS-04 Study
May 30, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Is Nvidia Worth 35x Times Sales, History Says No
May 29, 2024
You wouldn’t be able to tell just by looking at the S&P 500 daily change of +0.02%, but Tuesday was a pretty negative day, with the S&P 500 equal weight RSP ETF finishing down by almost 70 bps.
Via
Talk Markets
Topics
ETFs
Stocks
Exposures
US Equities
$100 Invested In This Stock 20 Years Ago Would Be Worth $800 Today
May 21, 2024
Via
Benzinga
Market Whales and Their Recent Bets on GILD Options
May 15, 2024
Via
Benzinga
2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years
May 28, 2024
These companies have grown their dividends despite some troubles.
Via
The Motley Fool
7 Biotech Stocks to Put on Your Breakthrough Radar
May 27, 2024
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance.
Via
InvestorPlace
3 Biotech Stocks to Buy Now: May 2024
May 22, 2024
As the biotech industry continues to rise in market prominence, investors should start considering what the best biotech stocks to buy are.
Via
InvestorPlace
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024
May 22, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Large Cap Biopharmaceuticals Performance
May 20, 2024
The biotech sector remains a laggard YTD as can be seen by the IBB.
Via
Talk Markets
Decoding Gilead Sciences's Options Activity: What's the Big Picture?
May 10, 2024
Via
Benzinga
Why NASDAQ:GILD qualifies as a good dividend investing stock.
May 09, 2024
Why GILEAD SCIENCES INC (NASDAQ:GILD) is a Top Pick for Dividend Investors.
Via
Chartmill
$1000 Invested In This Stock 20 Years Ago Would Be Worth $9,300 Today
May 07, 2024
Via
Benzinga
Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch
May 20, 2024
Gilead Sciences reports interim results from the ASSURE study of seladelpar in primary biliary cholangitis, showing significant improvements in cholestasis markers and pruritus.
Via
Benzinga
The P3 App: Empowering and Elevating Underprivileged Youth from Socioeconomically Disadvantaged Areas Through Innovative Mentorship
May 18, 2024
CHICAGO - May 18, 2024 - PRLog -- The Pulse of Perseverance alongside Gilead is proud to announce the launch of the P3 mobile app, a pioneering platform unveiled at our signature benefit event on May...
Via
PRLog
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
May 18, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Unusual Options Activity For May 06
May 06, 2024
Via
Benzinga
How Is The Market Feeling About Gilead Sciences?
May 06, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch
May 16, 2024
Penny stocks to buy understandably offers many enticing attributes, not least of which is the potential for tremendous returns.
Via
InvestorPlace
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
May 14, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
May 09, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
May 09, 2024
These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot.
Via
InvestorPlace
Gilead Sciences Unusual Options Activity
April 26, 2024
Via
Benzinga
Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
May 07, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Bargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back
May 06, 2024
If you want your shot at significant upside, speculate on these stocks near 52-week lows that can prove the critics wrong.
Via
InvestorPlace
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
May 01, 2024
These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.
Via
InvestorPlace
Gilead Sciences to Present at Upcoming Investor Conferences
April 30, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
3 Dividend Stocks to Buy at a 52-Week Low in April
April 26, 2024
Explore these three dividend stocks trading near their 52-week lows, presenting compelling opportunities for income-oriented investors.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
50
51
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.